Patents Assigned to Imtix-Sangstat
  • Method for increasing mean survival times of transplants with LFA-1-specific antibodies
    Patent number: 6214342
    Abstract: Mean survival times of a functional transplant of solid organs in a patient are increased by administering to the patient an initial dosing of a therapeutically effective amounts of a monoclonal antibody directed against the human LFA-1 molecule in the two hours after grafting and then administering daily dosing during a period of approximately nine days.
    Type: Grant
    Filed: October 30, 1995
    Date of Patent: April 10, 2001
    Assignee: Imtix-Sangstat
    Inventors: Gilles Alberici, Pierre Caudrelier, Brigitte Le Mauff, Maryvonne Hourmant, Jean-Paul Soulillou